A citation-based method for searching scientific literature

Hongchao Guo, Lichao Liu, Masataka Nishiga, Le Cong, Joseph C Wu. Trends Genet 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Network analysis reveals rare disease signatures across multiple levels of biological organization.
Pisanu Buphamalai, Tomislav Kokotovic, Vanja Nagy, Jörg Menche. Nat Commun 2021
4
33

Origins of human disease: the chrono-epigenetic perspective.
Edward Saehong Oh, Art Petronis. Nat Rev Genet 2021
6
33

Noncoding loci without epigenomic signals can be essential for maintaining global chromatin organization and cell viability.
Bo Ding, Ying Liu, Zhiheng Liu, Lina Zheng, Ping Xu, Zhao Chen, Peiyao Wu, Ying Zhao, Qian Pan, Yu Guo,[...]. Sci Adv 2021
2
50

Old drugs with new tricks.
Roderick L Beijersbergen. Nat Cancer 2020
6
33

Paediatric genomics: diagnosing rare disease in children.
Caroline F Wright, David R FitzPatrick, Helen V Firth. Nat Rev Genet 2018
186
33

Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database.
Stéphanie Nguengang Wakap, Deborah M Lambert, Annie Olry, Charlotte Rodwell, Charlotte Gueydan, Valérie Lanneau, Daniel Murphy, Yann Le Cam, Ana Rath. Eur J Hum Genet 2020
253
33

Genetic modifiers and oligogenic inheritance.
Maria Kousi, Nicholas Katsanis. Cold Spring Harb Perspect Med 2015
58
33

Human organoids: model systems for human biology and medicine.
Jihoon Kim, Bon-Kyoung Koo, Juergen A Knoblich. Nat Rev Mol Cell Biol 2020
381
33

Integrative Methods and Practical Challenges for Single-Cell Multi-omics.
Anjun Ma, Adam McDermaid, Jennifer Xu, Yuzhou Chang, Qin Ma. Trends Biotechnol 2020
60
33

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.
Damian Smedley, Katherine R Smith, Antonio Martin, Ellen A Thomas, Ellen M McDonagh, Valentina Cipriani, Jamie M Ellingford, Gavin Arno, Arianna Tucci, Jana Vandrovcova,[...]. N Engl J Med 2021
46
33

Decoding disease: from genomes to networks to phenotypes.
Aaron K Wong, Rachel S G Sealfon, Chandra L Theesfeld, Olga G Troyanskaya. Nat Rev Genet 2021
8
33

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.
Lucia A Hindorff, Praveen Sethupathy, Heather A Junkins, Erin M Ramos, Jayashri P Mehta, Francis S Collins, Teri A Manolio. Proc Natl Acad Sci U S A 2009
33


Non-human primates as a model for human development.
Tomonori Nakamura, Kohei Fujiwara, Mitinori Saitou, Tomoyuki Tsukiyama. Stem Cell Reports 2021
2
50

Gene regulation by long non-coding RNAs and its biological functions.
Luisa Statello, Chun-Jie Guo, Ling-Ling Chen, Maite Huarte. Nat Rev Mol Cell Biol 2021
686
33

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P Austin, Philip J Brooks, Kristina Larsson, Katherine I Miller Needleman, James Valentine, Kay Davies, Stephen C Groft, Robert Preti,[...]. Nat Rev Drug Discov 2020
77
33

Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X.
Yu Liu, Chunliang Li, Shuhong Shen, Xiaolong Chen, Karol Szlachta, Michael N Edmonson, Ying Shao, Xiaotu Ma, Judith Hyle, Shaela Wright,[...]. Nat Genet 2020
27
33

Joint utilization of genetic analysis and semi-cloning technology reveals a digenic etiology of Müllerian anomalies.
Lingbo Wang, Ying Zhang, Xiaoyi Fu, Shuangshuang Dong, Shuyan Tang, Ning Zhang, Chengcheng Song, Nan Yang, Lin Zhang, Hongyan Wang,[...]. Cell Res 2020
6
33

Patient-specific iPSC-derived cardiomyocytes reveal abnormal regulation of FGF16 in a familial atrial septal defect.
Lingqun Ye, You Yu, Zhen-Ao Zhao, Dandan Zhao, Xuan Ni, Yong Wang, Xing Fang, Miao Yu, Yongming Wang, Jun-Ming Tang,[...]. Cardiovasc Res 2022
5
33

Detection of Mycoplasma in cell cultures.
Lesley Young, Julia Sung, Glyn Stacey, John R Masters. Nat Protoc 2010
178
33

Human embryonic stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models.
You Yu, Nianci Qin, Xing-Ai Lu, Jingjing Li, Xinglong Han, Xuan Ni, Lingqun Ye, Zhenya Shen, Weiqian Chen, Zhen-Ao Zhao,[...]. Stem Cell Res Ther 2019
13
33

Long QT syndrome.
Ilan Goldenberg, Arthur J Moss. J Am Coll Cardiol 2008
295
33

Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
Dongrui Ma, Heming Wei, Yongxing Zhao, Jun Lu, Guang Li, Norliza Binte Esmail Sahib, Teng Hong Tan, Keng Yean Wong, Winston Shim, Philip Wong,[...]. Int J Cardiol 2013
109
33

Channelopathies That Lead to Sudden Cardiac Death: Clinical and Genetic Aspects.
Jonathan R Skinner, Annika Winbo, Dominic Abrams, Jitendra Vohra, Arthur A Wilde. Heart Lung Circ 2019
57
33

Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Ricardo Caballero, Raquel G Utrilla, Irene Amorós, Marcos Matamoros, Marta Pérez-Hernández, David Tinaquero, Silvia Alfayate, Paloma Nieto-Marín, Guadalupe Guerrero-Serna, Qing-Hua Liu,[...]. Proc Natl Acad Sci U S A 2017
19
33


Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.
Cecile Terrenoire, Kai Wang, Kelvin W Chan Tung, Wendy K Chung, Robert H Pass, Jonathan T Lu, Jyh-Chang Jean, Amel Omari, Kevin J Sampson, Darrell N Kotton,[...]. J Gen Physiol 2013
133
33

Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing.
Adrian Veres, Bridget S Gosis, Qiurong Ding, Ryan Collins, Ashok Ragavendran, Harrison Brand, Serkan Erdin, Chad A Cowan, Michael E Talkowski, Kiran Musunuru. Cell Stem Cell 2014
354
33

High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays.
Kristin H Gilchrist, Gregory F Lewis, Elaine A Gay, Katelyn L Sellgren, Sonia Grego. Toxicol Appl Pharmacol 2015
47
33

AKAP9 is a genetic modifier of congenital long-QT syndrome type 1.
Carin P de Villiers, Lize van der Merwe, Lia Crotti, Althea Goosen, Alfred L George, Peter J Schwartz, Paul A Brink, Johanna C Moolman-Smook, Valerie A Corfield. Circ Cardiovasc Genet 2014
36
33

A novel KCNH2 mutation as a modifier for short QT interval.
Hideki Itoh, Tomoko Sakaguchi, Takashi Ashihara, Wei-Guang Ding, Iori Nagaoka, Yuko Oka, Yuko Nakazawa, Takenori Yao, Hikari Jo, Makoto Ito,[...]. Int J Cardiol 2009
29
33

Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation.
Iva Synková, Markéta Bébarová, Irena Andršová, Larisa Chmelikova, Olga Švecová, Jan Hošek, Michal Pásek, Pavel Vít, Iveta Valášková, Renata Gaillyová,[...]. Sci Rep 2021
2
50

Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Dongrui Ma, Heming Wei, Jun Lu, Dou Huang, Zhenfeng Liu, Li Jun Loh, Omedul Islam, Reginald Liew, Winston Shim, Stuart A Cook. Stem Cell Res Ther 2015
61
33

A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes.
Razan Elfadil Ahmed, Tatsuya Anzai, Nawin Chanthra, Hideki Uosaki. Front Cell Dev Biol 2020
61
33

Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential.
Wataru Yamamoto, Keiichi Asakura, Hiroyuki Ando, Tomohiko Taniguchi, Atsuko Ojima, Takaaki Uda, Tomoharu Osada, Seiji Hayashi, Chieko Kasai, Norimasa Miyamoto,[...]. PLoS One 2016
44
33

Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
Iris C R M Kolder, Michael W T Tanck, Pieter G Postema, Julien Barc, Moritz F Sinner, Sven Zumhagen, Anja Husemann, Birgit Stallmeyer, Tamara T Koopmann, Nynke Hofman,[...]. Circ Cardiovasc Genet 2015
29
33

Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction.
Daniela Malan, Miao Zhang, Birgit Stallmeyer, Jovanca Müller, Bernd K Fleischmann, Eric Schulze-Bahr, Philipp Sasse, Boris Greber. Basic Res Cardiol 2016
61
33

The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Krzysztof Chylinski, Anaïs Le Rhun, Emmanuelle Charpentier. RNA Biol 2013
205
33

Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.
Yongming Wang, Ping Liang, Feng Lan, Haodi Wu, Leszek Lisowski, Mingxia Gu, Shijun Hu, Mark A Kay, Fyodor D Urnov, Rami Shinnawi,[...]. J Am Coll Cardiol 2014
107
33

KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.
Lia Crotti, Andrew L Lundquist, Roberto Insolia, Matteo Pedrazzini, Chiara Ferrandi, Gaetano M De Ferrari, Alessandro Vicentini, Ping Yang, Dan M Roden, Alfred L George,[...]. Circulation 2005
176
33

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1.
Manuela Mura, Francesca Bastaroli, Marzia Corli, Monia Ginevrino, Federica Calabrò, Marina Boni, Lia Crotti, Enza Maria Valente, Peter J Schwartz, Massimiliano Gnecchi. Stem Cell Res 2020
3
33


Historic Overview of Genetic Engineering Technologies for Human Gene Therapy.
Ryota Tamura, Masahiro Toda. Neurol Med Chir (Tokyo) 2020
3
33

Mouse models of long QT syndrome.
Guy Salama, Barry London. J Physiol 2007
98
33

Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
Nikhil V Chavali, Dmytro O Kryshtal, Shan S Parikh, Lili Wang, Andrew M Glazer, Daniel J Blackwell, Brett M Kroncke, Moore Benjamin Shoemaker, Bjorn C Knollmann. Heart Rhythm 2019
19
33

The G314S KCNQ1 mutation exerts a dominant-negative effect on expression of KCNQ1 channels in oocytes.
Wei Li, Rong Du, Qiu-Fen Wang, Li Tian, Jun-Guo Yang, Zi-Fang Song. Biochem Biophys Res Commun 2009
7
33

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis.
Kiera H Harwood, Rachel M McQuade, Andrew Jarnicki, Elena K Schneider-Futschik. Int J Mol Sci 2021
4
33

Induced Pluripotent Stem Cell-Derived Cardiomyocytes with SCN5A R1623Q Mutation Associated with Severe Long QT Syndrome in Fetuses and Neonates Recapitulates Pathophysiological Phenotypes.
Emiko Hayama, Yoshiyuki Furutani, Nanako Kawaguchi, Akiko Seki, Yoji Nagashima, Keisuke Okita, Daiji Takeuchi, Rumiko Matsuoka, Kei Inai, Nobuhisa Hagiwara,[...]. Biology (Basel) 2021
2
50

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
Elena Matsa, Divya Rajamohan, Emily Dick, Lorraine Young, Ian Mellor, Andrew Staniforth, Chris Denning. Eur Heart J 2011
265
33

From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2.
Peter J Schwartz, Massimiliano Gnecchi, Federica Dagradi, Silvia Castelletti, Gianfranco Parati, Carla Spazzolini, Luca Sala, Lia Crotti. Eur Heart J 2019
43
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.